Hantavirus Not the Same Scenario as COVID; Exposed US Patients Receiving 'Best Care,' Officials Say

USA TODAY
USA TODAYMay 11, 2026

Why It Matters

It reassures the public that hantavirus risk is limited while highlighting the need for vigilant containment, guiding health‑policy and resource allocation.

Key Takeaways

  • Patient in biocontainment unit remains asymptomatic, under observation.
  • Andes hantavirus can spread person‑to‑person, but usually after symptoms appear.
  • Transmission requires very close contact, not casual exposure.
  • Unlike COVID‑19, hantavirus is known; existing data guide response.
  • Officials pledge best medical care for quarantined and biocontainment patients.

Summary

The video features U.S. health officials addressing concerns about a recently admitted patient with the Andes strain of hantavirus, who is being housed in a high‑security biocontainment unit.

Officials note the patient remains asymptomatic and is being closely monitored. They explain that while Andes hantavirus can be transmitted person‑to‑person, transmission typically occurs only after the infected individual shows symptoms and requires very close contact.

A speaker emphasized, “There are a lot of unknowns,” but also stressed that hantavirus is not a novel pathogen like SARS‑CoV‑2, allowing clinicians to rely on existing knowledge to guide treatment and isolation protocols.

The clarification aims to reassure the public, underscore the importance of rapid containment, and signal that resources will continue to be allocated to manage any potential spread, influencing both healthcare preparedness and policy decisions.

Original Description

Seventeen Americans who were aboard the cruise ship at the center of the deadly hantavirus outbreak are expected to return to the United States early Monday, where they will first stop at an Air Force base before entering quarantine.
The U.S. passengers disembarked from the MV Hondius on Sunday after the ship was anchored near Tenerife, in Spain's Canary Islands.

Comments

Want to join the conversation?

Loading comments...